Literature DB >> 8890457

D2L, D2S, and D3 dopamine receptors stably transfected into NG108-15 cells couple to a voltage-dependent potassium current via distinct G protein mechanisms.

L X Liu1, F J Monsma, D R Sibley, L A Chiodo.   

Abstract

The D2-like dopamine (DA) receptor family has continued to expand and now includes the D2-short (D2S) and D2-long (D2L) receptor isoforms and the D3 and D4 receptors. The D2 receptor isoforms differ in length by 29 amino acids within the third cytoplasmic loop, a region of the receptor believed to be important for G protein coupling. This observation has led to the hypothesis that the two isoforms of the D2 receptor may utilize different signal transduction pathways when present in the same cell. The D2 and D3 receptors, although mostly different, show some common amino acid sequences within the third cytoplasmic loop. Thus, it is possible that the D2 and D3 receptors may employ similar signal transduction pathways. To test these hypotheses directly, NG108-15 neuroblastoma-glioma hybrid cells were stably transfected to express either the D2S, D2L, or D3 DA receptors. All transfected but not untransfected NG108-15 cells demonstrated a dose-dependent reduction in the peak whole-cell potassium (K+) current in response to receptor activation by DA or the DA receptor agonists quinpirole (QUIN) and apomorphine (APO). The modulation of K+ current by D2S receptor stimulation was prevented by pretreatment of the cells with cholera toxin (20 micrograms/ml for 18 h), whereas pertussis toxin pretreatment (500 ng/ml for 4 h) completely blocked the effects of D2L and D3 receptor activation. These observations suggest that the signal transduction mechanisms involved in coupling the two isoforms of the D2 receptor to the K+ current are different, whereas the D2L and D3 receptor coupling mechanisms may be similar. In direct support of this hypothesis, it was observed that the intracellular application of a polyclonal antibody that is specific for the GO alpha subunit completely blocked the ability of D2L and D3 receptors to modulate outward K+ currents. In contrast, the D2S-mediated modulation of K+ currents was blocked by intracellular application of an antibody recognizing GS alpha but not GO alpha. These findings demonstrate that D2S and D2L receptors are able to couple to a common effector in a cell via two G protein pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890457     DOI: 10.1002/(SICI)1098-2396(199610)24:2<156::AID-SYN7>3.0.CO;2-E

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  7 in total

1.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

Review 2.  Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.

Authors:  Amy E Moritz; R Benjamin Free; David R Sibley
Journal:  Cell Signal       Date:  2017-07-14       Impact factor: 4.315

3.  K+ channel modulation in rodent neurohypophysial nerve terminals by sigma receptors and not by dopamine receptors.

Authors:  R A Wilke; P J Lupardus; D K Grandy; M Rubinstein; M J Low; M B Jackson
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

4.  The histamine autoreceptor is a short isoform of the H₃ receptor.

Authors:  F Gbahou; A Rouleau; J-M Arrang
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 5.  Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors.

Authors:  Jaromir Myslivecek
Journal:  Life (Basel)       Date:  2022-04-19

6.  Functional coupling between heterologously expressed dopamine D(2) receptors and KCNQ channels.

Authors:  Trine Ljungstrom; Morten Grunnet; Bo Skaaning Jensen; Søren-Peter Olesen
Journal:  Pflugers Arch       Date:  2003-06-21       Impact factor: 3.657

Review 7.  Lipid Rafts and Dopamine Receptor Signaling.

Authors:  Victor J Martinez; Laureano D Asico; Pedro A Jose; Andrew C Tiu
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.